Fig. 2.
A schematic summary of pro-apoptotic and survival factors typically affecting the endothelial cell. A loss of survival factors will also precipitate apoptosis. ROS (reactive oxygen species), VEGF (Vascular endothelial cell growth factor). apoptosis in tissue sections. The major drawback of the TUNEL technique is that nuclei can be stained A schematic diagram illustrating four functional stages of apoptosis and the three major pathways through which the cascade non-specifically due to differences in cell fixation and of cellular events can proceed. The three pivotal caspases (8, 9 also non-nuclear structures in atherosclerotic plaques and 3) are shown with caspase-3, the final executioner, causing may be stained. It is recommended that this technique irreversible DNA damage and loss of cell viability. Control is achieved with the regulatory pro and anti-apoptotic proteins (Bax/ be used in conjunction with an additional morBid & Bcl2 respectively). TNF (Tumour necrosis factor/receptor), phological method. include the detection of externalised phosphatidylserine (PS) residues, that occurs in early apoptosis, with a fluorescein (FITC) conjugate of AnnexinBid) that facilitate the release of cytochrome C from the V, a protein that has a high natural affinity for PS. mitochondria. The relative amounts of these proteins This method allows quantitative assessment of apodetermines whether the cell undergoes apoptosis or ptotic cells either by fluorescence microscopy or flow not. Structural and morphological changes to the cell cytometry. occur following the internucleosomal fragmentation of DNA leading to an irreversible loss of cell viability. Early apoptotic cells are characterised by externalisation of phosphatidylserine (PS) residues, Pro-apoptotic Factors Implicated in Vascular Cell which are normally situated on the inner leaflet of the Apoptosis plasma membrane. This feature facilitates the specific recognition of apoptotic cells by macrophages enabling In vitro studies have shown that extracellular agents, their elimination by phagocytosis.
including well characterised cardiovascular risk facThe efficient removal of apoptotic cells can make tors and inflammatory mediators induce apoptosis of their identification difficult. Historically the detection endothelial cells and vascular SMCs. (Fig. 2) . and quantification of apoptotic cells has relied on morphological assessment by electron microscopy or light microscopy. 1 Newer techniques rely on the detection of fragmented DNA by terminal transferase Oxidised Low Density Lipoprotein (OxLDL) mediated dUTP-biotin nick end labelling (TUNEL) or in situ nick translation (ISEL). 7 Both methods have Elevated LDL is a significant risk factor for coronary artery disease. Specifically, its oxidised form (OxLDL) become the standard technique for the detection of is considered to play a key role in the development of premature atherosclerosis through the formation of foam cells and fatty streaks. 8 OxLDL is known to be cytotoxic to cultured endothelial cells and has also been shown to induce apoptosis, in bovine aortic endothelial cells and human umbilical vein endothelial cells (HUVECs). [9] [10] [11] OxLDL-induced apoptosis is inhibited by the addition of the antioxidant vitamins C and E, 12 and is therefore believed to act through the generation of reactive oxygen species. Cultured vascular smooth muscle cells also undergo apoptosis 
Hyperglycaemia/advanced glycation end products Cytokines and inflammatory mediators
Endothelial cells cultured with high concentrations of The inflammatory cytokines TNF , IL-1 and IFNglucose (30 mmol/L) for 48 h show increased apoptosis have all been identified in human atherosclerotic compared with those incubated in low concentrations plaques. 23 TNF causes endothelial cell apoptosis 24 of glucose (5 mmol/L). 15 High glucose also appears to through the activation of caspase-3 and may be ininduce apoptosis through the generation of hydrogen hibited by specific inhibitors of this enzyme. 25 Inperoxide and can be inhibited by antioxidants such terestingly, TNF can also activate a survival pathway as ascorbic acid. 16 Similarly high concentrations of that requires protein synthesis. 26 Inhibitors of RNA advanced glycation end products, the products of non-transcription or protein synthesis can therefore augenzymatic glycation of proteins in the circulation, can ment TNF -induced apoptosis of endothelial cells. In induce apoptosis of endothelial cells after 48 h. 17 In-contrast TNF , does not cause apoptosis of cultured terestingly, the lipid-lowering drug pravastatin can human smooth muscle cells on its own, but does so prevent hyperglycaemia induced apoptosis 18 which when combined with IL-1 and IFN-.
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Lipocontrasts with the proapoptotic effects of the lipophilic polysaccharide also induces human endothelial cell statins (atorvastatin, simvastatin and lovastatin) on apoptosis in vitro that can be prevented by antivascular smooth muscle cells.
oxidants.
12 This effect also occurs in vivo, but unlike the in vitro setting is dependent on TNF release. 28 Angiotensin II, although promoting growth of VSMCs, induces endothelial apoptosis in vitro in a dose dependent manner. 29 
Homocysteine
Hyperhomocysteinaemia is, an independent risk factor for cardiovascular disease, and, is known to cause
Reactive oxygen species endothelial dysfunction. 20 We have recently shown that homocysteine in combination with adenosine, an Elevated reactive oxygen species (ROS) are an early hallmark of atherogenesis. 30 In vitro evidence indicates important substrate in homocysteine metabolism, can induce apoptosis of cultured HUVECs and human that ROS, the by-product of aerobic metabolism, induce endothelial and smooth muscle cell apoptosis.
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long saphenous vein endothelial cells after as little as 4 h incubation 21 (Fig. 3) . These effects can be prevented ROS may be produced in the vessel wall by macrophages within the atherosclerotic plaque or endoby vitamin B6, B12 and folate, 22 cofactors in homocysteine metabolism and currently used as homo-genously by human endothelial and vascular smooth muscle cells. The proatherosclerotic and proapoptotic cysteine-lowering agents in clinical trials. The latter finding may represent an important mechanism by factors oxLDL, TNF , glucose and angiotensin II, all induce endogenous ROS whose effects can be prewhich vitamin supplementation can reduce vascular injury associated with hyperhomocysteinaemia.
vented by antioxidants.
Survival Factors Implicated in Preventing Cell-matrix interactions Vascular Cell Apoptosis
The survival of endothelial cells and vascular smooth muscle cells is dependent on contact with adjacent Shear stress and nitric oxide cells and the extracellular matrix (Fig. 2) . This is mediated by cellular adhesion molecules such as the Cultured endothelial cells (HUVECs) undergo a basal level of apoptosis in the absence of flow, which can be integrins, which also function as signalling molecules.
Apoptosis occurs when these contacts are lost. 46 Under inhibited by mimicking flow conditions in a perfusion chamber. 32 Laminar flow generates shear stress at the normal circumstances the extracellular matrix generates survival signals that either suppress apoptotic endothelial cell surface that can prevent apoptosis induced by different stimuli including TNF , oxLDL pathways or lead to an increase in the activity of anti-apoptotic pathways such as the Bcl-2 family of and ROS. This inhibition is mediated by shear stressinduced release of nitric oxide (NO) that subsequently proteins. 47 inactivates caspase-3. 33 In the normal vasculature the shear stress associated with laminar flow causes a continuous production of NO by endothelial cells, Apoptosis and Vascular Disease providing protection from injury and apoptosis. However atherosclerotic plaque-prone areas are typically Plaques sites of turbulent blood flow and low shear stress, and are associated with increased cell turnover, 34 which is Early studies in cholesterol-fed swine have shown most probably secondary to increased apoptosis. 35 cell death to be a major component of atherosclerotic plaque development. 48 In situ techniques (TUNEL) have since confirmed the presence of apoptotic smooth muscle cells, T-lymphocytes, and macrophages in Growth factors human atherosclerotic plaques. 27,49,50 More recently Tricot et al. 51 have examined carotid endarterectomy Cultured endothelial cells deprived of growth factor specimens and shown that apoptotic luminal endoundergo apoptosis. 36 Addition of vascular endothelial thelial cells occur with a greater prevalence in the growth factor (VEGF) can inhibit apoptosis induced post-stenotic area, a region of low flow and low shear by TNF , 37 ionising radiation 38 and disruption of the stress. extracellular matrix. 39 Angiopoietin-1 can also prevent Apoptotic cell death within plaques, as determined apoptosis in growth factor deprived endothelial cells. 40 by the TUNEL technique, ranges from <2% to 30% and Basic fibroblast growth factor (FGF-2) prevents lipo-is related to the stage of the atherosclerotic plaque. 27,49, popolysaccharide induced endothelial cell apoptosis in 50, [52] [53] [54] [55] Very little apoptosis occurs in intimal thickening vivo and serum and growth factor deprivation induced and fatty streaks with the majority of apoptotic cells apoptosis in vitro. 28, 36 In cultured human vascular occurring in advanced atherosclerotic plaques within smooth muscle cells several growth factors (insulin-regions of macrophage infiltration. 5 like growth factor, platelet derived growth factor, basic
Although the above evidence indicates that apofibroblast growth factor, and transforming growth fac-ptosis does occur within human atherosclerotic tor) inhibit apoptosis especially under low serum con-plaques, other authors have used electron microscopy ditions. [41] [42] [43] [44] to show that despite >10% TUNEL-positive nuclei, the vast majority of injured and disintegrating cells within plaques display typical features of cells undergoing cell death by necrosis. [56] [57] [58] Although the relative importance of cell death by Atheroprotective factors apoptosis versus necrosis is unknown we can speculate that apoptosis may allow plaque stabilisation. ApoOestrogen is an established atheroprotective hormone, which is known to produce beneficial changes in lipid ptotic removal of T-cells and macrophages, which commonly infiltrate the shoulder region of the fibrous profile and the regulation of vascular tone. Oestradiol also maintains endothelial integrity by inhibiting endo-cap, would reduce matrix metalloproteinase (MMP) synthesis and extracellular matrix breakdown without thelial apoptosis induced byTNF . 45 Antioxidant vitamins C and E, especially in combination, prevent an accompanying inflammatory reaction. Conversely death of vascular smooth muscle cells in plaques, apoptosis induced by oxLDL, TNF , and glucose. Apoptosis of luminal endothelial cells 51 in athero-found in transplant arteriopathy. Experimental evidence using rat arterial allografts suggest that this sclerotic plaques may initiate plaque erosion with the subsequent promotion of platelet aggregation and SMC loss is due to apoptosis. 68 Endothelial damage, also seen in transplant arteriopathy, appears to be due thrombosis. Apoptotic vascular cells themselves may also lead to increased plaque thrombogenicity. Both to a Fas-based apoptotic pathway. 69 apoptotic smooth muscle cells and endothelial cells expose phosphatidylserine residues on their surface in early apoptosis, which in the presence of factor V Therapeutic Potential and VII, can act as a substrate for the generation of thrombin. 59 Additionally apoptotic monocytic cells Apoptotic cells are quickly eliminated by neighbouring have enhanced tissue factor activity. 60 Mallat et al. 61 phagocytic cells making in vivo identification difficult. have also identified increased tissue factor expression Our current understanding of apoptosis in vascular around apoptotic cells within the central necrotic core disease therefore depends almost entirely upon in vitro of plaques, indicating that tissue factor is shed from and in situ data. However, recent techniques, which apoptotic cells via apoptotic microparticles.
capture shed microparticles released by apoptotic cells, have been used to show increased apoptosis in acute coronary artery syndromes.
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Restenosis Induction of apoptosis Apoptosis of smooth muscle cells will occur following Atherosclerotic plaques in cholesterol-fed rabbits reballoon injury in animal models. An initial apoptotic gress when neointimal cell apoptosis is induced by response after 30 min 62 is followed by persistent apoinhibiting the antiapoptotic protein Bcl-x. 71 Plaque reptosis after two weeks, the latter associated with the gression also occurs following administration of Lregulation of intimal thickening. 63 Studies of human arginine to induce macrophage apoptosis via NO rerestenotic plaques indicate there may be an increased lease. 72 Interestingly, Schaub et al. 73 found that when apoptotic rate, but there is no consensus. Isner et al. 52 vascular smooth muscle cell apoptosis is induced, found an increased apoptotic rate in human restenotic through the overexpression of death domain proteins, plaques, whereas Bauriedel et al. 64 noted reduced levels macrophages are recruited and neointimal progression of apoptotic cells in restenotic plaques compared with rather than regression occurs. primary plaques.
Various attempts to induce apoptosis have been tried in animal models of neointima formation and restenosis following angioplasty. Transfection of suicide genes into smooth muscle cells or direct delivery of pro-apoptotic ligands (Fas-ligand) into the vessel Aneurysms wall induce smooth muscle cell apoptosis and a significant reduction in neointima formation in rabbit Reduced smooth muscle cell density within the elastic arteries following angioplasty. 74 Adopting this apmedia of human aneurysmal wall is associated with proach in the human clinical setting may however, increased smooth muscle cell apoptosis. [65] [66] [67] Further risk the development of aneurysms. evidence has shown that infiltrating T cells express cytotoxic mediators such as cytokines, perforin and Fas/Fas ligand, which are capable of inducing apoptosis. It is hypothesised that these might contribute
Inhibition of apoptosis to the elimination of smooth muscle cells, a source of collagen and elastin, thereby impairing repair and Currently there is no information on the effect of inhibiting apoptosis on the progression or commaintenance of the arterial extracellular matrix tending to favour aneurysmal wall expansion.
plications of vascular disease. In vitro and in situ data 
